Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

Myelodysplastic syndrome (MDS) represents a heterogeneous group of diseases with clonal proliferation, bone marrow failure and increasing risk of transformation into an acute myeloid leukaemia. Structured guidelines are developed for selective therapy based on prognostic subgroups, age, and performa...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Stintzing, Sebastian, Kemmerling, Ralf, Kiesslich, Tobias, Alinger, Beate, Ocker, Matthias, Neureiter, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2011
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100562/
https://ncbi.nlm.nih.gov/pubmed/21629744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/214143
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia